As an unexpected histologic finding after transurethral resection of the prostate or radical prostatectomy, the cancer has usually spread beyond the prostate capsule at the time of diagnosis.

both in terms of imaging and histology. Further work is ongoing. The first reported use of PDT for prostate cancer in the clinical setting was in 1990, which used tissue-based photosensitizers.

But other tests, such as imaging scans and additional pathology findings, are typically performed to figure out if any cancer has moved beyond the boundaries of the prostate gland before ...

Micro-ultrasound–guided biopsies were found for the first time to be “noninferior” to MRI-guided procedures, according to new research presented at the 2025 annual congress of the European ...

Opens in a new tab or window A polygenic risk score was able to detect a high proportion of clinically significant prostate cancer. Cancer would not have been detected in 71.8% of patients with ...

The AI Test combines clinical data and digital pathology to calculate prognostic risk scores and determine the risk of ...

assessment of the drug's biochemical and physiological effects on the body and its mechanism of action against cancer cells. Key inclusion criteria for the study includes patients who are 18 years or ...

Formula One team owner Eddie Jordan has died, aged 76, after a year-long battle with prostate and bladder cancer. The Irishman revealed in December he was suffering from bladder and prostate ...

Just eight months after undergoing robotic surgery to remove his cancerous prostate, Mark Cwiek, a 70-year-old track and ...